HOME >> MEDICINE >> NEWS
Treatment helped reduce dose of inhaled corticosteroids while maintaining asthma control

Study found Study found that patients on Advair Diskus (fluticasone propionate and salmeterol inhalation powder) 100/50 BID maintained asthma control compared with fluticasone propionate 250 mcg BID alone, at 60 percent reduction in inhaled corticosteroids.

SAN DIEGO (November 6, 2002) -- An asthma treatment that contains both an inhaled long-acting bronchodilator and an inhaled corticosteroid was as effective at providing overall asthma control as more than double the dose of the inhaled corticosteroid alone, according to a study presented today at CHEST 2002, the annual scientific meeting of the American College of Chest Physicians.

This "inhaled corticosteroid-sparing" effect is an important consideration in asthma therapy. According to asthma treatment guidelines issued by the National Institutes of Health, inhaled corticosteroids are the most effective long-term-control medications available for the treatment of asthma.1 Though inhaled corticosteroids are generally well-tolerated at recommended doses, asthma treatment guidelines recommend that patients should use the lowest dose necessary for asthma control to help optimize the risk/benefit ratio for individual patients.1

The study compared Advair Diskus 100/50 -- which contains 100 mcg of fluticasone propionate (an inhaled corticosteroid) and 50 mcg of salmeterol (an inhaled long-acting bronchodilator) -- twice daily with fluticasone propionate 250 mcg twice daily. The study involved 558 patients 12 years of age and older who required fluticasone propionate 250 mcg twice daily for asthma control.

Advair Diskus is the first and only product to effectively treat the two main causes of asthma symptoms -- inflammation and bronchoconstriction -- in one easy-to-use2 device. Advair Diskus does not replace fast-acting inhalers to treat sudden symptoms.

In this study, Advair Diskus 100/50 twice daily was used to reduce the dose of inhaled corticosteroids by 60 p
'"/>


6-Nov-2002


Page: 1 2 3

Related medicine news :

1. Treatment of cardiac lesions without anaesthesic
2. Treatment guidelines for kids with bipolar disorder published
3. University of Washington joins new Autism Treatment Network to provide better medical services
4. Treatment for brain tumor does not always follow recommendations
5. Advances in Skeletal Anabolic Agents for the Treatment of Osteoporosis: A scientific meeting
6. Treatment of ductal carcinoma in situ varies widely in United States
7. Treatment options expand for patients with neuropathic pain
8. Treatment interruption shows no benefit in drug-resistant HIV infection
9. Peanut Allergy: Major Advances in Treatment and Education
10. Release of results of Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
11. Treatment for behavioral disorders in children with autism

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2018)... ... August 14, 2018 , ... Health & hygiene ... Report , which is the largest study of brands based on emotions. In the ... in the Top 10 for the health & hygiene industry were: Listerine, Nivea, Gillette, ...
(Date:8/11/2018)... ... August 10, 2018 , ... TopConsumerReviews.com recently ... , What is gout? This painful, persistent condition originates in the liver and ... levels of uric acid. Other contributing factors may be medication side effects, overweight, ...
(Date:8/9/2018)... (PRWEB) , ... August 09, 2018 , ... Lyme disease ... reported per year skyrocketing to an estimated 329,000 – a 25-fold increase since surveillance ... , Lyme disease can be found all 50 states and the District of Columbia. ...
(Date:8/7/2018)... ... August 07, 2018 , ... Josh Sprague, Founder and CEO ... video preview for the upcoming Leadville 100 MTB. , Accompanied by colleague Marvin ... what he has called “one of the most iconic mountain bike race courses in ...
(Date:8/3/2018)... ... ... On August 2, 2018 the JPML ordered that the Zostavax MDL be assigned ... been litigating Zostavax injuries since 2011. , On July ... thousands of people injured by Zostavax, a vaccine given to adults to prevent shingles. ...
Breaking Medicine News(10 mins):
(Date:8/9/2018)... ... August 09, 2018 , ... National Day ... cbdMD named the exclusive sponsor. , “We’re honored to have been selected as ... embrace for CBD on a national level,” said cbdMD’s Chief Scientific Officer, Dr. ...
(Date:8/7/2018)... ... 07, 2018 , ... Penn State graduate, Dr. Kevin Pauza, ... begun training and certifying spine physicians across the United States on his technique ... at the Weill Cornell Brain and Spine Center in July, and have begun ...
(Date:8/3/2018)... (PRWEB) , ... August 03, 2018 , ... Flexefits, a ... passing H.R. 6199, especially for its allowing participants in Direct Primary Care arrangements to ... by HSAs (capped at $150 per individual and $300 per family per month.) , ...
Breaking Medicine Technology:
Cached News: